TB care for women and Covid-A double health crisis in the offing?

Abstract

The COVID-19 pandemic and its health, economic and social aftermath has currently overshadowed every other health concern throughout the world. There are numerous ways in which this will impact existing public health issues. In this article we aim to examine and reflect on the interactions between COVID-19 and tuberculosis (TB) another scourge which has long been the world’s leading infectious killer. There are potentially grave consequences for existing and undiagnosed TB patients globally, particularly in low and middle income countries like India where TB is endemic and health services poorly equipped. TB control programmes are likely to be strained due to diversion of resources, and an inevitable loss of health system focus. This is likely to lead to a reduction in quality of TB care and worse outcomes. The symptoms of TB and COVID-19 can be similar, for instance symptoms like cough and fever. Not only can this create diagnostic confusion, but it could worsen the stigmatization of TB patients especially in LMICs, given the fear of COVID-19. Women with TB in India are a vulnerable group as gender disparities play a significant role in how men and women access healthcare in the public and private sectors. They are especially likely to suffer as part of the “collateral damage” and also experience the impact of the double stigma disproportionately. In this paper the researchers examine the impact of Covid 19 on women seeking TB care in India.